Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press40610.17650/1994-4098-2014-0-4-29-34MAMMOLOGY. DIAGNOSISМАММОЛОГИЯ. ДИАГНОСТИКАTactics of radiographic diagnostics of breast cancer in women with inherited predispositionТактика лучевой диагностики рака молочной железы у женщин с наследственной предрасположенностьюKarpovaM. S.КарповаМ. С.
Russian Federation
mskarpova@bk.ruKorzhenkovaG. P.КорженковаГ. П.
Russian Federation
LyubchenkoL. N.ЛюбченкоЛ. Н.
Russian Federation
N.N. Blokhin Russian Cancer Research Cancer, MoscowФГБНУ «Российский онкологический научный центр им. Н.Н. Блохина» , Москва081120144293406012015060120152014https://ojrs.abvpress.ru/ojrs/article/view/406

With conventional approaches to mammography tissue examination in women over 40 years of age, mammography has been found to be lesseffective for a group of younger women with negative family histories (cancer in the family) and BRCA1 and BRCA2 gene mutation carriers.A distinct approach to mammography tissue examination in women with a hereditary disposition, involving additional examination methodswith due regard for age, is therefore suggested.

Сегодня разработана тактика обследования ткани молочных желез у женщин старше 40 лет. Но группа женщин с наследственной предрасположенностью требует отдельного подхода с использованием дополнительных методов обследования и учетом возрастных особенностей ткани молочных желез. Маммография оказалась малоэффективной в группе молодых женщин с отягощенным семейным анамнезом (семейный рак) и носителей мутаций генов BRCA1 и BRCA2. В связи с этим встал вопрос о введении в скрининговую программу женщин высокого риска дополнительных методов, которые бы позволили выявлять рак молочной железы в доклинической стадии.

breast cancermagnetic resonance imagingmammographyBRCA1BRCA2рак молочной железымагнитно-резонансная томографиямаммографияBRCA1BRCA21. Breast Cancer Linkage Consortium (BCLC). Familial Cancer 2003;2(3–4):18–32.Breast Cancer Linkage Consortium (BCLC). Familial Cancer 2003;2(3–4):18–32.2. Antoniou A., Pharoah P.D., Narod S. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analisys of 22 studies. Am J Hum Genet 2003;72(5):1117–30.Antoniou A., Pharoah P.D., Narod S. et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analisys of 22 studies. Am J Hum Genet 2003;72(5):1117–30.3. Nathanson K.L., Wooster R., Weber B.L. Breast cancer genetics: what we know and what we need. Nat Med 2001;7(5):552–6.Nathanson K.L., Wooster R., Weber B.L. Breast cancer genetics: what we know and what we need. Nat Med 2001;7(5):552–6.4. Brekelmans C.T., Seynaeve C., Bartels C.C. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 2001;19(4):924–30.Brekelmans C.T., Seynaeve C., Bartels C.C. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk. J Clin Oncol 2001;19(4):924–30.5. Scheuer L., Kauff N., Robson M. et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 2002;20(5): 1260–8.Scheuer L., Kauff N., Robson M. et al. Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers. J Clin Oncol 2002;20(5): 1260–8.6. Komenaka I.K., Ditkoff B.A., Joseph K.A. et al. The development of interval breast malignancies in patients with BRCA mutations. Cancer 2004;100(10):2079–83.Komenaka I.K., Ditkoff B.A., Joseph K.A. et al. The development of interval breast malignancies in patients with BRCA mutations. Cancer 2004;100(10):2079–83.7. Goffin J., Chappuis P.O., Wong N., Foulkes W.D. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001;93(22):1754–5.Goffin J., Chappuis P.O., Wong N., Foulkes W.D. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001;93(22):1754–5.8. Houssami N., Cuzick J., Dixon J.M. The prevention, detection, and management of breast cancer. Med J Aust 2006;84(5): 230–4.Houssami N., Cuzick J., Dixon J.M. The prevention, detection, and management of breast cancer. Med J Aust 2006;84(5): 230–4.9. Stomper P.C., D’Souza D.J., DiNitto P.A., Arredondo M.A. Analysis of parenchymal density on mammograms in 1353 women 25–79 year old. Am J Roentgenol 1996;167(5):1261–5.Stomper P.C., D’Souza D.J., DiNitto P.A., Arredondo M.A. Analysis of parenchymal density on mammograms in 1353 women 25–79 year old. Am J Roentgenol 1996;167(5):1261–5.10. Lehman C.D., White E., Peacock S. et al. Effect of age and breast density on screening mammograms with false-positive findings. AJR Am J Roentgenol 1999;173(6):1651–5.Lehman C.D., White E., Peacock S. et al. Effect of age and breast density on screening mammograms with false-positive findings. AJR Am J Roentgenol 1999;173(6):1651–5.11. Kolb T.M., Lichy J., Newhouse J.H. Occult cancer in women with dense breasts: detection with screening US-diagnostic yield and tumor characteristics. Radiology 1998;207(1): 191–9.Kolb T.M., Lichy J., Newhouse J.H. Occult cancer in women with dense breasts: detection with screening US-diagnostic yield and tumor characteristics. Radiology 1998;207(1): 191–9.12. Zonderland H.M., Coerkamp E.G., Hermans J. еt аl. Diagnosis of breast cancer: contribution of US as an adjunct to mammography. Radiology 1999;213(2): 413–22.Zonderland H.M., Coerkamp E.G., Hermans J. еt аl. Diagnosis of breast cancer: contribution of US as an adjunct to mammography. Radiology 1999;213(2): 413–22.13. Rosenberg R.D., Hunt W.C., Williamson M.R. et al. Effect of age, breast density, ethnicity and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: Review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 1998;209(2):511–8.Rosenberg R.D., Hunt W.C., Williamson M.R. et al. Effect of age, breast density, ethnicity and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: Review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology 1998;209(2):511–8.14. Davis P.L., McCarty K.S. Jr. Sensitivity of enhanced MRI for detection of breast cancer: new, multicentric, residual, and recurrent. Eur Radiol 1997;7 Suppl 5:289–98.Davis P.L., McCarty K.S. Jr. Sensitivity of enhanced MRI for detection of breast cancer: new, multicentric, residual, and recurrent. Eur Radiol 1997;7 Suppl 5:289–98.15. Orel S.G., Schnall M.D. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220(1):13–30.Orel S.G., Schnall M.D. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001;220(1):13–30.16. Heywang-Kobrunner S.H., Viehweg P., Heinig A., Kuchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 1997;24(2):94.108.Heywang-Kobrunner S.H., Viehweg P., Heinig A., Kuchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 1997;24(2):94.108.17. Kriege M., Brekelmans C.T., Boetes C. „ut al.; Magnetic Resonance Imaging Screening Study Group. Efficacy of breast cancer screening with MRI and mammography in women with a familial or genetic predisposition. N Eng J Med 2004;351(5): 427.37.Kriege M., Brekelmans C.T., Boetes C. „ut al.; Magnetic Resonance Imaging Screening Study Group. Efficacy of breast cancer screening with MRI and mammography in women with a familial or genetic predisposition. N Eng J Med 2004;351(5): 427.37.18. Wakeford R. The cancer epidemiology of radiation. Oncogene 2004;23(38): 6404.28.Wakeford R. The cancer epidemiology of radiation. Oncogene 2004;23(38): 6404.28.19. Jansen-van der Weide M.C, Greuter M.J., Jansen L. et al. Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis. Eur Radiol 2010;20(11):2547.56.Jansen-van der Weide M.C, Greuter M.J., Jansen L. et al. Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis. Eur Radiol 2010;20(11):2547.56.20. Broeks A., Braaf L.M., Huseinovic A. et al. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study. Breast Cancer Res 2007;9(2):106.14.Broeks A., Braaf L.M., Huseinovic A. et al. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study. Breast Cancer Res 2007;9(2):106.14.21. Leach M.O., Boggis C.R., Dixon A.K. et al; MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005;365(9473):1769.78.Leach M.O., Boggis C.R., Dixon A.K. et al; MARIBS study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005;365(9473):1769.78.22. Warner E., Plewes D.B., Hill K.A. et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292(11):1317.25.Warner E., Plewes D.B., Hill K.A. et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292(11):1317.25.23. Kuhl C.K., Schrading S., Leutner C.C. et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23(33):8469.76.Kuhl C.K., Schrading S., Leutner C.C. et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23(33):8469.76.24. Lehman C.D., Blume J.D., Weatherall P. et al.; International Breast MRI Consortium Working Group. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005;103(9):1898.905.Lehman C.D., Blume J.D., Weatherall P. et al.; International Breast MRI Consortium Working Group. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005;103(9):1898.905.25. Sardanelli F., Podo F., D'Agnolo G. et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007;242(3):698.715.Sardanelli F., Podo F., D'Agnolo G. et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 2007;242(3):698.715.